Adam H Schechter

CIK 1376841 · President & CEO · last filed 2026-08-18

Adam H Schechter is a President & CEO who has filed 121 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for DVA, was dated Aug 18, 2026. Across all open-market trades the lifetime net is −$80.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $62.7M across reported positions. 58 SEC filings were submitted jointly with LABORATORY CORP OF AMERICA HOLDINGS.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$62.66M

Companies

3

Total Filings

121

Lifetime Open-Market Net

-$80.15M

Filer Profile

Reported Address

531 SOUTH SPRING STREET
BURLINGTON, NC 27215

Related Filers

LABORATORY CORP OF AMERICA HOLDINGS — 58 joint filings, latest 2026-08-12

Merck & Co., Inc. — 41 joint filings, latest 2018-11-02

DAVITA INC. — 17 joint filings, latest 2026-08-18

MERCK SHARP & DOHME LLC — 15 joint filings, latest 2009-11-04

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
DVA	Director	5,970	$178.47	$1.07M	$0	16	2026-08-18
LH	President & CEO	102,565	$309.64	$31.76M	-$14.69M	46	2026-08-12
MRK	EVP & Pres-Global Human Health	200,540	$148.78	$29.84M	-$65.46M	50	2018-11-02

Recent Filings

121 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-08-18	DVA	Grant (A)	+278	$0	EDGAR
2026-08-12	LH	Sell (S)	−4,669	-$1.50M	EDGAR
2026-08-11	LH	Notice (144)	−4,669	-$1.50M	EDGAR
2026-05-18	DVA	Grant (A)	+250	$0	EDGAR
2026-05-13	LH	Sell (S)	−5,903	-$1.50M	EDGAR
2026-05-11	LH	Notice (144)	−5,903	-$1.50M	EDGAR
2026-03-30	LH	Mixed	+32,364	-$7.01M	EDGAR
2026-03-17	DVA	Grant (A)	+332	$0	EDGAR
2026-03-05	LH	Sell (S)	−8,705	-$2.44M	EDGAR
2026-03-03	LH	Notice (144)	−8,705	-$2.44M	EDGAR

Showing 1–10 of 121

Page 1 of 13 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.